We are live on ! Find out more
IWB icon

iShares Russell 1000 ETF

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 66.7%
Negative 33.3%

Negative
Seeking Alpha
5 days ago
IWB: Diversified By Count, Concentrated By Bet
The iShares Russell 1000 ETF (IWB) faces macroeconomic and valuation headwinds, with recent performance lagging due to hyperscaler concentration and rising rates. IWB's heavy weighting in technology and communication services increases its sensitivity to interest rate changes and exposes it to sector-specific risks. Geopolitical tensions and oil shocks have re-anchored inflation expectations, while persistent core inflation limits the likelihood of near-term Fed rate cuts.
IWB: Diversified By Count, Concentrated By Bet
Neutral
Morningstar
1 month ago
3 ETFs Likely to Hold SpaceX
How and when these index ETFs will add Mega-IPOs. What Happens If Tesla and SpaceX Merge?
3 ETFs Likely to Hold SpaceX
Neutral
ETF Trends
1 month ago
Rosenbluth Discusses ETF Implications of the SpaceX IPO on Yahoo! Finance
VettaFi Head of Research Todd Rosenbluth appeared on Yahoo! Finance to discuss the implications of the highly anticipated SpaceX IPO on the ETF market.
Rosenbluth Discusses ETF Implications of the SpaceX IPO on Yahoo! Finance
Neutral
Zacks Investment Research
1 month ago
Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?
The iShares Russell 1000 ETF (IWB) was launched on May 15, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US equity market.
Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?
Neutral
ETF Trends
2 months ago
Dual Commencement: The Russell Index Shift to Semi-Annual Rebalancing
June is typically reserved for graduation processionals, with the “Pomp and Circumstance March No. 1 in D” blaring from PA systems or high-fidelity systems (depending on how well-funded the school is).
Dual Commencement: The Russell Index Shift to Semi-Annual Rebalancing
Negative
Seeking Alpha
2 months ago
Russell U.S. Indexes Spotlight - Quarterly Report: April 2026
The Middle East crisis led to a broad selloff in Russell equity segments in March halting the year-long rally. 12M forward P/Es derated broadly but more so for Russell 1000, Top 200 and the large- and small-cap Growth indices partly due to their heavy Tech exposure and valuation expansion over the last three years.
Russell U.S. Indexes Spotlight - Quarterly Report: April 2026
Neutral
Zacks Investment Research
3 months ago
Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?
Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the iShares Russell 1000 ETF (IWB), a passively managed exchange traded fund launched on May 15, 2000.
Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?
Negative
Seeking Alpha
3 months ago
IWB: High Multiple Means High Sensitivity To Reinflation Risk
The iShares Russell 1000 ETF offers broad U.S. market exposure but is nearly identical to IVV with a tech-heavy allocation but higher expenses. Rising capital costs associated with heightened geopolitical uncertainty, especially from ongoing Middle East conflicts, are a major risk to high-multiple stocks. High multiples in IWB's megacap tech holdings are vulnerable to rising discount rates.
IWB: High Multiple Means High Sensitivity To Reinflation Risk
Neutral
Zacks Investment Research
5 months ago
Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?
Launched on May 15, 2000, the iShares Russell 1000 ETF (IWB) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.
Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?
Negative
Seeking Alpha
5 months ago
Polen Focus Growth Portfolio  Q4 2025 Performance, Attribution & Portfolio Activity
Eli Lilly's stock price has underperformed this year, much of it on the back of drug pricing concerns, potential tariff impacts and, perhaps, less enthusiasm for GLP-1 drugs. The primary drag for the quarter was Oracle, accounting for almost all of the Portfolio's relative underperformance in Q4, completely reversing its performance from the prior quarter and giving back all of the gains experienced in Q3. Polen Capital initiated a 2.25% position in Intuitive Surgical who maintain a de facto monopoly in soft tissue robotic surgery globally.
Polen Focus Growth Portfolio  Q4 2025 Performance, Attribution & Portfolio Activity